P175 Capsule endoscopy for small bowel Crohn’s disease—should we trust in magnetic resonance enterography?
S. Xavier*1,2,3, P. Boal Carvalho1,2,3, F. Dias de Castro1,2,3, J. Magalhães1,2,3, B. Rosa1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3
1Hospital da Senhora da Oliveira, Guimarães, Gastroenterology, Guimarães, Portugal, 2School of Medicine, University of Minho, Braga, Portugal, 3ICVS/3B’s Associate Laboratory, University of Minho, Braga/Guimarães, Portugal
Currently, both small bowel capsule endoscopy (SBCE) and magnetic resonance enterography (MRE) can be used to assess small bowel involvement in Crohn’s disease (CD). However, SBCE appears to be more sensitive in the detection of mild and proximal lesions. We aimed to compare the diagnostic yield for both techniques.
Adult patients with either confirmed or suspected Crohn’s disease who were submitted to both CE and MRE were retrospectively reviewed. Only patients performing SBCE and MRE within 3 months were included and patients with changes in CD therapy during this period were excluded.
Presence of ulcers, villous oedema and stenosis were assessed in SBCE, and patients with Lewis score (LS) ≥135 were considered to have significant inflammation. SB wall thickening, hyperenhancement, oedema, comb sign or presence of ulcers were considered signs of active CD in MRE.
Included 30 patients (53.3% suspected and 46.7% confirmed CD) with a median age of 31 ± 11 years, 56.7% of which were females. Comparing SBCE and MRE, SBCE had a significantly higher diagnostic yield (90.0% vs. 53.3%,
In our cohort, SBCE showed a significant overall higher diagnostic yield than MRE, with higher detection of distal lesions and, more importantly, SBCE identified proximal lesions in nearly half of examination while MRE was unable to identify any case. MRE diagnostic yield was more heavily influenced by the severity of inflammatory activity, being significantly inferior to SBCE in patients with mild inflammatory activity.